XNCR Q4 2018 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+5.7% YoY

Gross Profit

-$16M-134.6% margin

Operating Income

-$21M-182.3% margin

Net Income

-$18M-157.4% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-60.2%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$20M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$577M

Total Liabilities

$55M

Stockholders' Equity

$522M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$11M	+5.7%
Gross Profit	-$16M	$11M	-242.3%
Operating Income	-$21M	-$14M	-51.9%
Net Income	-$18M	-$12M	-53.7%